Don Rockey to Antiviral Agents
This is a "connection" page, showing publications Don Rockey has written about Antiviral Agents.
Connection Strength
2.432
-
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside. Gastroenterology. 2021 04; 160(5):1502-1520.e1.
Score: 0.610
-
Fibrosis reversal after hepatitis C virus elimination. Curr Opin Gastroenterol. 2019 05; 35(3):137-144.
Score: 0.540
-
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus. Clin Liver Dis. 2016 11; 20(4):667-679.
Score: 0.454
-
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J Viral Hepat. 2006 May; 13(5):322-8.
Score: 0.219
-
Hepatitis C virus treatment with direct-acting antivirals induces rapid changes in the hepatic proteome. J Viral Hepat. 2021 11; 28(11):1614-1623.
Score: 0.158
-
Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding. Aliment Pharmacol Ther. 2020 02; 51(3):364-373.
Score: 0.141
-
Editorial: Advances in Hepatology: 2019. Curr Opin Gastroenterol. 2019 05; 35(3):135-136.
Score: 0.135
-
A potential novel use for direct antiviral therapy. Hepatology. 2013 Jan; 57(1):414-5.
Score: 0.087
-
Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med. 2004 Oct 15; 117(8):619-20.
Score: 0.049
-
Linkage to specialty care in the hepatitis C care cascade. J Investig Med. 2021 02; 69(2):324-332.
Score: 0.038